Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Isentress (raltegravir) / Merck (MSD)

NCT00738569: Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen

Completed

N/A

Raltegravir, Brand name is Isentress

National Jewish Health, Merck Sharp & Dohme LLC

HIV

02/11

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites